Canada Wearables in Pharma & Biotech Market (2026-2031)
The Canada Wearables in Pharma & Biotech Market was valued at $111.88 Million in 2026 and projected to reach to $235.21 Million by 2031, representing a compound annual growth rate of 16.0%. Canada's wearables in pharma and biotech market is positioned for sustained expansion as healthcare providers prioritize digital transformation and remote monitoring capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada Wearables in Pharma & Biotech Market Trends and Insights
- This 16.0% compound annual growth rate reflects Canada's increasing adoption of digital health technologies and remote patient monitoring solutions across the healthcare sector.
- Canada's strong regulatory framework and healthcare infrastructure are driving investment in wearable devices for clinical trials, chronic disease management, and real-world evidence collection. The Canadian market benefits from a well-established life sciences ecosystem and growing partnerships between pharmaceutical companies and technology providers.
- Canada's aging population and emphasis on preventive healthcare are accelerating demand for wearable sensors and monitoring devices.
- By 2031, Canada is expected to solidify its position as a key hub for wearable innovation in North America, supported by government initiatives and private sector investment in digital health solutions..
Key Market Statistics
- CAGR (2026-2031) 16.0% CAGR
- Market Size, 2026 ~USD 111.88 Million
- Forecast, 2031 ~USD 235.21 Million
- Country Canada
Canada Wearables in Pharma & Biotech Market Overview
Market Valuation Growth :
Canada's wearables in pharma and biotech market is valued at $111.88 million in 2026, with projections reaching $235.21 million by 2031, representing a robust 16% CAGR over the forecast period.
Digital Health Adoption :
Canadian healthcare providers are increasingly integrating wearable technologies for remote patient monitoring and chronic disease management, driven by the country's advanced digital health infrastructure and patient-centric care models.
Regulatory Advantage :
Canada's Health Canada regulatory framework provides a clear pathway for wearable device approval, fostering innovation and attracting biotech companies to develop and commercialize next-generation monitoring solutions.
Healthcare System Integration :
The Canadian public healthcare system's emphasis on preventive care and cost-efficiency is accelerating wearable adoption for real-time health data collection, improving patient outcomes and reducing hospital readmissions.
Canada Wearables in Pharma & Biotech Market Dynamics
- The country's universal healthcare system, combined with strong government support for health technology innovation, creates a favorable environment for wearable device deployment across clinical and consumer segments. Key growth drivers include increasing prevalence of chronic diseases, aging population demographics, and rising healthcare costs that incentivize adoption of preventive monitoring solutions.
- Canadian biotech companies and international players are investing in localized wearable solutions tailored to the country's regulatory standards and healthcare delivery models, ensuring continued market momentum through 2031..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Canada's wearables in pharma & biotech market is valued at $111.88 million in 2026 and will reach $235.21 million by 2031, representing a 16.0% CAGR.
- Canada's regulatory environment and healthcare infrastructure create favorable conditions for wearable device adoption in clinical trials and patient monitoring.
- Canada's aging demographic and focus on preventive care are key drivers of wearable technology demand across the pharmaceutical and biotech sectors.
- Canada is positioned as a strategic North American hub for wearable innovation, supported by strong life sciences partnerships and government digital health initiatives.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
Canada Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
CANADA: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 28.2 | 32.6 | 37.9 | 44.1 | 51.5 | 60.3 | 70.8 | 83.2 | 17.1 |
| HEALTHCARE PROVIDERS & CLINICIANS | 9 | 10.2 | 11.6 | 13.2 | 15.2 | 17.5 | 20.2 | 23.3 | 15 |
| OTHER END USERS | 5.3 | 6 | 6.7 | 7.6 | 8.7 | 9.9 | 11.2 | 12.8 | 13.6 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 42.5 | 48.5 | 55.7 | 64.2 | 74.2 | 85.9 | 99.7 | 115.9 | 15.8 |
| TOTAL | 85 | 97.3 | 111.9 | 129.1 | 149.5 | 173.6 | 201.9 | 235.2 | 16 |
Target Audience
- Biotech & Pharma Companies : Canadian and international biotech firms need market intelligence to develop wearable-integrated drug delivery systems and clinical trial monitoring solutions aligned with Health Canada regulations and healthcare provider requirements.
- Medical Device Manufacturers : Device makers require detailed market data on Canadian adoption rates, reimbursement policies, and healthcare system integration needs to optimize product development and commercialization strategies for the Canadian market.
- Healthcare Providers & Hospitals : Canadian hospitals and clinics need insights into wearable technology ROI, patient outcomes data, and integration capabilities to make informed procurement decisions and improve remote patient monitoring programs.
- Investment & Venture Capital Firms : Investors targeting Canadian health tech need comprehensive market sizing, growth projections, and competitive analysis to identify high-potential wearable companies and fund allocation opportunities in the sector.
- Government & Health Policy Bodies : Canadian health authorities and policy makers require market data to inform digital health strategy, reimbursement frameworks, and innovation incentives that support wearable technology adoption across provincial healthcare systems.
Key Companies in the Canada Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for Canada's wearables market with detailed 2026-2031 projections, enabling accurate budgeting and investment planning tailored to the Canadian healthcare landscape.
- Regulatory & Compliance Insights : Understand Health Canada's approval pathways and regulatory requirements specific to wearable devices, reducing time-to-market and ensuring compliant product launches in the Canadian market.
- Competitive Landscape Analysis : Identify key Canadian and international players operating in the wearables space, their market positioning, and strategic initiatives to inform competitive strategy and partnership opportunities.
- Healthcare System Integration Strategies : Gain insights into how Canadian provincial health systems are adopting wearables for remote monitoring and chronic disease management, enabling targeted go-to-market approaches for healthcare providers.
- Growth Driver Identification : Understand demographic trends, healthcare spending patterns, and technology adoption rates specific to Canada that are fueling 16% CAGR growth, supporting long-term business planning and expansion strategies.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in Canada?
Canada's wearables in pharma and biotech market is valued at $111.88 million in 2026, with expectations to grow significantly through 2031.
What is the projected market size for Canada's wearables in pharma & biotech by 2031?
Canada's market is projected to reach $235.21 million by 2031, representing more than a doubling of the 2026 valuation.
What is the CAGR for Canada's wearables in pharma & biotech market?
Canada's wearables in pharma and biotech market is growing at a compound annual growth rate of 16.0% from 2026 to 2031.
What factors are driving growth in Canada's wearables market?
Canada's growth is driven by an aging population, strong regulatory frameworks, healthcare infrastructure investments, and increasing adoption of remote patient monitoring and digital health solutions.
How does Canada's wearables market compare to global trends?
Canada's 16.0% CAGR is competitive within North America, reflecting strong regional demand for wearable technologies in pharmaceutical and biotech applications.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report